Two-fraction Versus Five-fraction Stereotactic Body Radiotherapy for Intermediate-risk Prostate Cancer: The TOFFEE Meta-analysis of Individual Patient Data from Four Prospective Trials.
Udovicich C, Cheung P, Chu W, Chung H, Detsky J, Liu S, Morton G, Szumacher E, Tseng CL, Vesprini D, Ong WL, Kennedy T, Davidson M, Ravi A, McGuffin M, Zhang L, Mamedov A, Deabreu A, Kulasingham-Poon M, Loblaw A.
Udovicich C, et al. Among authors: zhang l.
Eur Urol Oncol. 2025 Feb 3:S2588-9311(24)00298-0. doi: 10.1016/j.euo.2024.12.015. Online ahead of print.
Eur Urol Oncol. 2025.
PMID: 39904690